|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Clinical and angiographic outcome of intracranial aneurysms treated with Matrix detachable coils in Chinese patients 显示文摘 | Wong GKC FRCS (SN) Yu SCH | 2007 | Surg Neurol2007，67，： | 1 |
| 2 | Clinical and angiographic outcome of intracranial aneurysms treated with Matrix detachable coils in Chinese patients显示文摘 | Wong GKC FRCS (SN) Yu SCH | 2007 | Surg Neurol2007，67，： | 1 |
| 3 | 2D-3D vascular registration between digital subtraction angiographic(DSA) and magnetic resonance angiographic (MRA) images显示文摘 | Chan HM Chung ACS Yu SCH | 1999 | IEEE International Symposium on Biomedical Image1999，，1： | 1 |
| 4 | Treatment of pyogenic liver abscess: prospective randomized comparison of catheter drainage and needle aspiration显示文摘 | YU SCH HO SSM LAU WY | 2004 | Hepatology2004，39，4： | 1 |
| 5 | 11 C-acetate PET imaging in hepatocellular carcinoma and other liver masses显示文摘 | Ho CL Yu SCH Yeung DWC | 2003 | J Nucl Med2003，44，2： | 1 |
| 6 | Percutaneous local ablative therapy for hepatocellular carcinoma 显示文摘 | Lau WY Leung WT Yu SCH Ho SKW | 2003 | Ann Surg2003，237，： | 1 |
| 7 | Methods for prediction of peptide binding to MHC molecules:a comparative study显示文摘 | Yu K Petrovsky N Sch?nbach C | | 0，，03： | 1 |
| 8 | Complete obliteration of intracranial arteriovenous malformation with endovascular cyanoacrylate embolization:initial success and rate of permanent cure显示文摘 | Chan MSY Lam JMK | 2004 | Am J Neuroradiol2004，25，： | 1 |
| 9 | 11C -Acetate PET imaging in hepatocellular carcinoma and other liver masses显示文摘 | Ho CL Yu SCH Yeung D | 2003 | J Nucl Med2003，44，2： | 1 |
| 10 | Multidisciplinary management of life-threatening massive hemoptysis:a 10-year experience显示文摘 | Shigemura N Wan IY Yu SCH Wong RH Hsin MKY Thung HK Lee T-W Wan S Underwood M J yim APC | 2009 | Ann Thorac Surg2009，87，3： | 1 |
| 11 | 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses显示文摘 | Ho CL Yu SCH Yeung DWC | | 0，，： | 1 |
| 12 | Relations between structure and catalytic activity of Ce–In-ZSM-5 catalysts for the selective reduction of NO by methane显示文摘 | T. Sowade T. Liese C. Schmidt F.-W. Schütze X. Yu H. Berndt W. Grünert | 2004 | Journal of Catalysis2004，，1： | 1 |
| 13 | Direct injection of cispatin/epinephrine injectable gel for treatment of hepatocellular carcinoma显示文摘 | Yu SCH Leng TWT Lau WY | 2000 | HPB2000，2，： | 1 |
| 14 | A serum microRNA signature for enhanced selection of people for lung cancer screening显示文摘Dear editor,Lung cancer(LC)is the leading cause of cancer-related mortality globally[1].Earlier detection by screening can substantially reduce LC mortality[2,3],but should be focused on those at highest risk[4].Risk stratification for LC screening,which is mostly based on smoking history[5],is far from perfect[6].Therefore,additional criteria to better define those at highest risk of LC are needed to enhance the efficiency and cost-effectiveness of LC screening.Besides risk prediction models incorporating classical LC risk factors[7]. | Haixin Yu Janhavi R.Raut Megha Bhardwaj Yan Zhang Evelin Sandner Ben Schöttker Bernd Holleczek Petra Schrotz-King Hermann Brenner | 2022 | Cancer Communications2022，42，11： | 0 |
| 15 | Gut microbiota research nexus:One Health relationshipbetween human,animal,and environmental resistomes显示文摘The emergence and rapid spread of antimicrobial resistance is of global public health concern.The gut microbiota harboring diverse commensal and opportunistic bacteria that can acquire resistance via horizontal and vertical gene transfers is considered an important reservoir and sink of antibiotic resistance genes(ARGs).In this review,we describe the reservoirs of gut ARGs and their dynamics in both animals and humans,use the One Health perspective to track the transmission of ARG-containing bacteria between humans,animals,and the environment,and assess the impact of antimicrobial resistance on human health and socioeconomic development.The gut resistome can evolve in an environment subject to various selective pressures,including antibiotic administration and environmental and lifestyle factors(e.g.,diet,age,gender,and living conditions),and interventions through probiotics.Strategies to reduce the abundance of clinically relevant antibiotic-resistant bacteria and their resistance determinants in various environmental niches are needed to ensure the mitigation of acquired antibiotic resistance.With the help of effective measures taken at the national,local,personal,and intestinal management,it will also result in preventing or minimizing the spread of infectious diseases.This review aims to improve our understanding of the correlations between intestinal microbiota and antimicrobial resistance and provide a basis for the development of management strategies to mitigate the antimicrobial resistance crisis. | Yuhao Fu Qingyuan Dou Kornelia Smalla Yu Wang Timothy A.Johnson Kristian K.Brandt Zhi Mei Maoyuan Liao Syed A.Hashsham Andreas Schäffer Hauke Smidt Tong Zhang Hui Li Robert Stedtfeld Hongjie Sheng Benli Chai Marko Virta Xin Jiang Fang Wang Yong-Guan Zhu James M.Tiedje | 2023 | mLife2023，2，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员